-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

634A.O1.6 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Advancing Treatment Paradigms in Myeloproliferative Neoplasms and Mastocytosis

Symposia: Myeloproliferative Syndromes: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Adult, Combination therapy, Epidemiology, MPN, Drug development, Clinical Research, Chronic Myeloid Malignancies, Therapy sequence, Diseases, Treatment Considerations, Real-world evidence, Biological therapies, Registries, Myeloid Malignancies, Study Population, Human
Sunday, December 8, 2024: 4:30 PM-6:00 PM
Grand Hall D (Manchester Grand Hyatt San Diego)
Moderators:
Firas El Chaer, MD, Univesity of Virginia and William Shomali, MD,
Disclosures:
El Chaer: SPD Oncology: Consultancy, Research Funding; Amgen: Consultancy, Research Funding; CTI BioPharma: Consultancy; AbbVie: Consultancy; MorphoSys: Consultancy; Association of Community Cancer Centers: Consultancy; PharmaEssentia: Consultancy, Research Funding; Bristol Myers Squib: Consultancy, Research Funding; Geron: Consultancy; Sobi: Consultancy; DAVA Oncology: Consultancy, Other: Travel grant; Celgene: Research Funding; Sanofi: Research Funding; FibroGen: Research Funding; BioSight: Research Funding; MEI Pharma: Research Funding; Novartis: Research Funding; Arog Pharmaceuticals: Research Funding.
4:30 PM

Firas El Chaer, MD1, Lindsay A.M. Rein, MD2, Junichiro Yuda, MD, PhD3, Kazuya Shimoda, MD, PhD4, Akiyoshi Takami, MD, PhD5, Michiko Ichii, MD, PhD6*, James McCloskey, MD7, Joseph M. Scandura, MD, PhD8, Alessandra Iurlo, MD, PhD9*, Prithviraj Bose, MD10, Tamanna Haque, MD11*, Alessandro Lucchesi, MD, PhD12*, Shuichi Shirane, MD, PhD13*, Giulia Benevolo, MD14*, Idoroenyi Amanam, MD15, Jean-Jacques Kiladjian, MD, PhD16, Pankit Vachhani, MD17*, Srinivas K Tantravahi, MD18, Yasushi Onishi, MD, PhD19*, Ciro Rinaldi, MD, PhD20*, Marcello Rotta, MD21*, Nikki Granacher, MD22*, Anand Ashwin Patel, MD23, Michael Loschi, MD, PhD24*, Samah Alimam, MD, PhD25*, Terrence Bradley, MD26, Stanley Cheung, MD, PhD27*, Vincent Ribrag, MD28, Sujan Kabir, MD29*, Karen Ansaldo, PharmD29*, Masataka Seki, MS29*, Vincent Loksa, PharmD29*, Zhonggai Li, PhD29*, Jason M. Foulks, PhD29, Jatin Shah, MD29 and Raajit Rampal, MD, PhD11

1University of Virginia Health System, Charlottesville, VA
2Duke University Medical Center, Durham, NC
3National Cancer Center Hospital East, Kashiwa, Japan
4University of Miyazaki, Miyazaki, Japan
5Aichi Medical University School of Medicine, Nagakute, Japan
6Osaka University Graduate School of Medicine, Suita, Japan
7John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, NJ
8Weill Cornell Medicine, New York, NY
9Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
10The University of Texas MD Anderson Cancer Center, Houston, TX
11Memorial Sloan Kettering Cancer Center, New York, NY
12IRCCS Istituto Romagnolo per lo Studio e la Cura dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
13Juntendo University School of Medicine, Bunkyo-ku, Japan
14AOU Città della Salute e della Scienza, Turin, Italy
15City of Hope National Medical Center, Duarte, CA
16Hopital Saint-Louis, Paris, France
17University of Alabama at Birmingham, Birmingham, AL
18Huntsman Cancer Institute, Salt Lake City, UT
19Tohoku University Hospital, Sendai, Japan
20Pilgrim Hospital Boston, Boston, United Kingdom
21Colorado Blood Cancer Institute, Denver, CO
22ZNA Middelheim, Antwerp, Belgium
23University of Chicago, Chicago, IL
24CHU de Nice - Hôpital L'Archet 1, Nice, France
25University College of London Hospitals NHS Foundation Trust, London, United Kingdom
26University of Miami Health System, Miami, FL
27ICON Cancer Care, Kurralta Park, Australia
28Institut Gustave Roussy, Villejuif, France
29Sumitomo Pharma America, Inc., Marlborough, MA

4:45 PM

Marina Kremyanskaya, MD, PhD1, Ronald Hoffman, MD2, Lee Ping Chew, MD, MRCP3*, Azizan Sharif, MBBS4*, Boyan Semov5*, Ahlam Naila Kori, MD6*, Hanlon Sia, MBBS FRACP FRCPA7*, Carolyn S. Grove, MBBS, FRACP, FRCPA, PhD8, Ashley P Ng, MBBS, PhD9*, Akash Kalro, MD10, Indu Raman, MBBS11*, Ganesh Kasinathan, MD12*, Olubunmi Oduwole13*, Monica Gomez-Palou, PhD13*, Henry Fok, MBBS PhD13*, Steve Romano, MD13*, Curtis Rambaran, MD PhD13* and Alberto Martinez, PhD13

1Division of Hematology & Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
2Tisch Cancer Institute, Department of Medicine, Division of Hematology/Oncology, Myeloproliferative Neoplasm-Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY
3Hospital Umum Sarawak, Sarawak, Malaysia
4Hospital Sultanah Aminah, Johor, Malaysia
5Medical Centre Leo Clinic EOOD, Plovdiv, Bulgaria
6Department of Haematology, Hospital Tengku Ampuan Afzan, Kuantan, Malaysia
7Pindara Private Hospital, Gold Coast, Australia
8Sir Charles Gairdner Hospital, Nedlands, Australia
9Clinical Haematology, Peter MacCallum Cancer Centre & the Royal Melbourne Hospital, Melbourne, VIC, Australia
10Royal Adelaide Hospital, Adelaide, Australia
11Epworth HealthCare, Melbourne, VIC, Australia
12Hospital Sultanah Nur Zahirah, Kuala Terengganu, Malaysia
13Silence Therapeutics, London, United Kingdom

5:00 PM

Naseema Gangat, MBBS1, James M. Foran, MD2, Anna B. Halpern, MD3,4, Raajit Rampal, MD, PhD5, Prithviraj Bose, MD6, Elizabeth O. Hexner, MD, MSTR7, Moshe Talpaz, MD8, Laura C. Michaelis, MD9, Prioty Islam, MD10*, Ronan T. Swords, MD, PhD, FRCP, FRCPath11, Sima Bhatt12, Akshay Buch, PhD12*, Olivia Pelletier, MBA12*, Will Savage, MD, PhD12 and Ayalew Tefferi, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Hematology & Medical Oncology, Mayo Clinic, Jacksonville, FL
3University of Washington, Seattle, WA
4Fred Hutchinson Cancer Center, Seattle, WA
5Memorial Sloan Kettering Cancer Center, New York, NY
6The University of Texas MD Anderson Cancer Center, Houston, TX
7Abramson Cancer Center, Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA
8University of Michigan Cancer Center, Ann Arbor, MI
9Division of Hematology/Oncology, Department of Medicine, The Medical College of Wisconsin Inc, Milwaukee, WI
10Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
11Knight Cancer Institute, Oregon Health & Science University, Portland, OR
12Disc Medicine, Watertown, MA

5:15 PM

Justin M. Watts, MD1, Anthony M. Hunter, MD2, Alessandro Vannuchhi, MD3*, Vikas Gupta, MD, FRCP, FRCPath4, Srinivas K Tantravahi, MD5, Alessandra Iurlo, MD, PhD6*, Brandon McMahon, MD7, Francesca Palandri, MD, PhD8*, María Teresa Gómez Casares, MD, PhD9*, Junichiro Yuda, MD, PhD10*, Emma Searle11,12*, Anna B. Halpern, MD13,14, Rosa Ayala, MD, PhD15*, Akihiro Tomita, MD, PhD16*, Blanca Xicoy, MD17*, Prithviraj Bose, MD18, Brandi N. Reeves, MD19, Xuejun Chen, PhD20*, Lea M Burke, MS20*, Feng Zhou, PhD20*, Fred Zheng, MD20* and Pankit Vachhani, MD21*

1Sylvester Cancer Center, University of Miami, Miami, FL
2Emory University Winship Cancer Institute, Atlanta, GA
3AOU Careggi, University of Florence, Florence, Italy
4Princess Margaret Cancer Centre, Toronto, Canada
5Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
6Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
7University of Colorado Anschutz Medical Campus, Aurora, CO
8IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
9Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
10National Cancer Center Hospital East, Chiba, Japan
11The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom
12The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
13University of Washington, Seattle, WA
14Fred Hutchinson Cancer Center, Seattle, WA
15Hospital Universitario 12 De Octubre, Madrid, Spain
16Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan
17Hematology Service, Hospital Germans Trias I Pujol, Institut Català Oncologia, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
18The University of Texas MD Anderson Cancer Center, Houston, TX
19University of North Carolina School of Medicine, Chapel Hill, NC
20Incyte Corporation, Wilmington, DE
21O'Neal Comprehensive Cancer Center at the UAB, Birmingham, AL

5:30 PM

Daniel J. DeAngelo, MD, PhD1, Jason Gotlib, MD, MS2, Vinod Pullarkat, MD3, Pankit Vachhani, MD4*, Tsewang Tashi, MD5, Stephanie Lee, MD, MSc, FRCPC6, Gary J. Schiller, MD7, Anthony M. Hunter, MD8, Miguel Piris-Villaespesa, MD9*, Helena Pomares10*, Bulai Livideanu Cridtina11*, Khalid Shoumariyeh, MD12*, Jonathan Lambert, PhD, BSc, BMBS, FRCP, FRCPath13*, Tracy I. George, MD14, Jay Patel, MD15, Cristina Papayannidis, MD, PhD16, Tania Jain, MD17, Michael W. Deininger, MD, PhD18, Andreas Reiter, MD19, Gabriela S. Hobbs, MD20, Lei Sun21*, Deepak Nagendra22*, Jenna Zhang, PhD21*, Amanda Pilla21*, Kim Dishman21*, Marcus Carden, MD21* and Deepti H. Radia, MD23*

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Department of Medicine, Division of Hematology, Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA
3City of Hope, La Canada, CA
4Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
5Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
6Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada
7David Geffen School of Medicine at UCLA, Los Angeles, CA
8Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
9Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain
10Clinical Hematology Department, ICO-Hospitalet, Hospital Durán i Reynals. IDIBELL, Barcelona., Barcelona, Spain
11Department of Dermatology, CEREMAST Toulouse, CHU Toulouse, Toulouse, France
12Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
13Department of Haematology, University College Hospital, University College of London Hospitals NHS Foundation Trust, London, United Kingdom
14University of Utah and ARUP Laboratories, Salt Lake City, UT
15University of Utah, ARUP Laboratories, Salt Lake City, UT
16IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
17Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
18Deininger Lab, Versiti Blood Research Institute, Milwaukee, WI
19Department of Hematology and Oncology, University Medical Centre Mannheim, Mannheim, Germany
20Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA
21Cogent Biosciences, Waltham, MA
22Cogent Biosciences, Waltham
23NHS Foundation Trust, Guy's and St. Thomas' Hospital, London, United Kingdom

5:45 PM

Johannes Luebke, MD1*, Nicole Naumann, PhD1*, Georgia Metzgeroth, MD1*, Hans-Peter Horny, MD2*, Karl Sotlar, MD3*, Martina Rudelius, MD4*, Alice Fabarius, PhD1*, Wolf-Karsten Hofmann, MD1, Juliana Schwaab, MD1* and Andreas Reiter, MD1

1Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany
2Institute of Pathology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany
3University Hospital, Paracelsus Medical University, Salzburg, AUT
4Institute of Pathology, Hospital of the Ludwig-Maximilians-University (LMU), Munich, Germany

*signifies non-member of ASH